NCT06376838View on ClinicalTrials.gov

To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet

NACompletedINTERVENTIONAL
Enrollment

218

Participants

Timeline

Start Date

July 7, 2020

Primary Completion Date

October 15, 2021

Study Completion Date

May 4, 2023

Conditions
Crow's Feet Lines
Interventions
DEVICE

DLMR01

Experimental and Acitve Comparator are applied 1 time to each of crow's feet on both sides of the subject.

DEVICE

Rejuran

Experimental and Acitve Comparator are applied 1 time to each of crow's feet on both sides of the subject.

Trial Locations (1)

06973

Chung-ang University Hospital, Seoul

All Listed Sponsors
lead

DEXLEVO

INDUSTRY

NCT06376838 - To Prove the Non-inferiority of DLMR01 by Evaluating the Injecting Efficacy and Safety DLMR01 and Control for Patients in Crow's Feet | Biotech Hunter | Biotech Hunter